Givinostat alone [79] or in combination with azacytidine (a DNA methyltransferase inhibitor) [80] was shown to reduce inflammation by suppressing IFN-γ production, resulting in a significant reduction of tumour growth. This evidence concerns the gene IFNG and neoplasm.